News

STRATA Skin Sciences Appoints Dr. Uri Geiger to Chairman of its Board of Directors

HORSHAM, Pa., June 30, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to…

12 months ago

AEON Biopharma and Priveterra Announce Arrangement of Up to $125 Million of Financing in Connection with Proposed Business Combination

Financing represents minimum cash required to consummate the business combination and bridge AEON through key episodic migraine data readoutIRVINE, Calif.,…

12 months ago

CytomX Therapeutics Announces $30 Million Private Placement from BVF Partners L.P.

- Financing is expected to extend cash runway into the 2nd half of 2025 based on current operating plans, enabling…

12 months ago

TerrAscend Announces $37 Million Paydown of Senior Secured Term Loan in Pennsylvania

TORONTO, June 30, 2023 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (CSE: TER) (OTCQX: TRSSF), a leading North…

12 months ago

Jushi Holdings Inc. Completes Previously Disclosed Amendments to 12% Second Lien Notes and Warrants

BOCA RATON, Fla., June 30, 2023 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF),…

12 months ago

Castellum, Inc. Generates Record Monthly Revenue

Castellum, Inc. Generates Record Monthly Revenue Castellum, Inc. (the “Company”) (NYSE-American: CTM) record $4.25 million in unaudited revenue for May…

12 months ago

Enterome announces first patient dosed in a Phase 1/2 trial with third OncoMimics™ immunotherapy, EO4010, in Metastatic Colorectal Cancer

EO4010 uniquely mimics five distinct tumor-associated antigens designed to provide multi-targeted, broad tumor coverage, maximizing tumor killing and preventing immune…

12 months ago

Immuron Chairman Transition

MELBOURNE, Australia, June 30, 2023 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated…

12 months ago

Samsung Bioepis Releases 2023 Sustainability Report

Highlights key initiatives that will drive the company’s transition towards a more sustainable businessReaffirms commitment to environmentally and socially responsible…

12 months ago

Vistin Pharma ASA: Offer to buy back shares

30 June 2023: Vistin Pharma ASA (the “Company”) has decided to launch an offer to all shareholders in the Company…

12 months ago